Skip to content
September 24, 2022

Equity.Guru

Investment information for the new generation

Valeo Pharma (VPH.C) – Investor Roundtable #3

Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public markets pitfalls.

Today, we examine once again, Valeo Pharma (VPH.C), a Canadian-based specialty pharma company bringing already approved products from other regions and making them available in the Canadian marketplace. Their therapeutic offerings are in respiratory, oncology, neurology and specialty indications.

Enjoy!

More on

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x